What is the current Halozyme Therapeutics share price?
The current share price of Halozyme Therapeutics is 18.26.
How many Halozyme Therapeutics shares are in issue?
Halozyme Therapeutics has 132,098,000 shares in issue.
What is the market cap of Halozyme Therapeutics?
The market capitalisation of Halozyme Therapeutics is USD 2.41 B.
What is the 1 year trading range for Halozyme Therapeutics share price?
Halozyme Therapeutics has traded in the range of US$ 18.26 to US$ 18.26 during the past year.
What is the PE ratio of Halozyme Therapeutics?
The price to earnings ratio of Halozyme Therapeutics is 22.53.
What is the cash to sales ratio of Halozyme Therapeutics?
The cash to sales ratio of Halozyme Therapeutics is 7.65.
What is the reporting currency for Halozyme Therapeutics?
Halozyme Therapeutics reports financial results in USD.
What is the latest annual turnover for Halozyme Therapeutics?
The latest annual turnover of Halozyme Therapeutics is USD 829.25M.
What is the latest annual profit for Halozyme Therapeutics?
The latest annual profit of Halozyme Therapeutics is USD 281.59M.
What is the registered address of Halozyme Therapeutics?
The registered address for Halozyme Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801.
What is the Halozyme Therapeutics website address?
The website address for Halozyme Therapeutics is www.halozyme.com.
Which industry sector does Halozyme Therapeutics operate in?
Halozyme Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector.
Register for real-time alerts, custom portfolio, and market movers
Hot Features
Premium
